← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $169B	2,404	+148	+7%	$197B
2	2 Amgen AMGN $238B	1,892	+96	+5%	$96.2B
3	3 Eli Lilly LLY $1.13T	1,561	+130	+9%	$95.6B
4	4 Becton Dickinson BDX $52.5B	1,346	+30	+2%	$51.8B
5	5 McKesson MCK $116B	856	+5	+0.6%	$18.4B
6	6 Conagra Brands CAG $6.87B	705	-8	-1%	$8.82B
7	7 Regeneron Pharmaceuticals REGN $83B	671	+27	+4%	$27.4B
8	8 Lamb Weston LW $7.46B	615	+71	+13%	$8.94B
9	9 AstraZeneca AZN $261B	558	+13	+2%	$17.7B
10	10 Teva Pharmaceutical Industries Limited TEVA $48.2B	552	-4	-0.7%	$10.6B
11	11 Novo Nordisk NVO $175B	550	-7	-1%	$8B
12	12 ResMed RMD $33.8B	502	+5	+1%	$11.1B
13	13 DaVita DVA $11.9B	451	-39	-8%	$7.61B
14	14 West Pharmaceutical WST $26.8B	355	+1	+0.3%	$6.83B
15	15 DELISTED WW International WW	270	-27	-9%	$2.38B
16	16 DELISTED CATALENT, INC. CTLT	267	-10	-4%	$4.54B
17	17 Herbalife HLF $1.54B	253	-8	-3%	$8.46B
18	18 Medifast MED $138M	247	-19	-7%	$1.42B
19	19 Accendra Health ACH $24.9M	210	-9	-4%	$381M
20	20 Opko Health OPK $1.22B	202	-1	-0.5%	$428M
21	21 Fresenius Medical Care FMS $11.8B	197	-25	-11%	$370M
22	22 Tootsie Roll Industries TR $2.94B	178	+6	+3%	$483M
23	ARNA 23 DELISTED Arena Pharmaceuticals Inc ARNA	177	+17	+11%	$1.56B
24	24 Viking Therapeutics VKTX $3.44B	168	+20	+14%	$360M
25	25 Dr. Reddy's Laboratories RDY $10.9B	146	+21	+17%	$770M